Found 13 hits for monomerid = 50105106 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Voltage-gated L-type calcium channel
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.34E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Binding affinity against L-type calcium channel verapamil site |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
Delta-type opioid receptor
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Inhibition of ligand binding to human delta opioid receptor. |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
Adrenergic receptor alpha-1
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | MMDB
KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.15E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Inhibition of alpha-1 adrenergic receptor |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 480 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Inhibition of human dopamine receptor D2 |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
Muscarinic acetylcholine receptor M2
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.57E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Binding affinity against muscarinic acetylcholine receptor M2 |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
D(3) dopamine receptor
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 154 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Inhibition of human dopamine receptor D3 |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Binding affinity against mu opiate receptor |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
Muscarinic acetylcholine receptor M1
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.78E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Binding affinity against M1 muscarinic receptor |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
5-hydroxytryptamine receptor 7
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 849 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Inhibition of human 5-hydroxytryptamine 7 receptor |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.91E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Inhibition of human ORL1 orphanin receptor |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
Kappa-type opioid receptor
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Binding affinity against opioid receptor kappa 1 by using [3H]U-69593 as radioligand |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
D(4) dopamine receptor
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.69E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Inhibition of human dopamine receptor D4.4 |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |
D(1A) dopamine receptor
(Homo sapiens (Human)) | BDBM50105106
(1-[1-(2-Chloro-4-methyl-benzyl)-piperidin-4-yl]-1,...)Show SMILES Cc1ccc(CN2CCC(CC2)n2c3ccccc3[nH]c2=O)c(Cl)c1 Show InChI InChI=1S/C20H22ClN3O/c1-14-6-7-15(17(21)12-14)13-23-10-8-16(9-11-23)24-19-5-3-2-4-18(19)22-20(24)25/h2-7,12,16H,8-11,13H2,1H3,(H,22,25) | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.74E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille
Curated by ChEMBL
| Assay Description Inhibition of human dopamine receptor D1 |
J Med Chem 44: 3391-401 (2001)
BindingDB Entry DOI: 10.7270/Q2057GN9 |
More data for this Ligand-Target Pair | |